Sangamo BioSciences | Capitale Sociale E Riserve





Capitale Sociale E Riserve Cambiamento Data
Alaunos Therapeutics USD 2.8M 858K 2025-09
Alnylam Pharmaceuticals USD 233.89M 16.7M 2025-09
Alterity Therapeutics Limited AUD 22.81M 5.29M 2023-06
Amgen USD 9.62B 2.19B 2025-09
Bayer EUR 29.7B 799M 2025-09
BioCryst Pharmaceuticals USD -387.89M 33.7M 2025-09
Biogen USD 18.21B 573.5M 2025-09
BioMarin Pharmaceutical USD 6.06B 29.6M 2025-09
Cipla INR 329.19B 16.3B 2025-09
Clal Biotechnology ILS 121.41M 4.62M 2023-12
Compugen USD 43.83M 6.43M 2025-09
CSL USD 21.41B 861M 2025-06
Gilead Sciences USD 21.46B 1.78B 2025-09
GlaxoSmithKline GBP 16.38B 229M 2025-12
Grifols EUR 6.08B 34.72M 2025-09
Ionis Pharmaceuticals USD 617.97M 13.76M 2025-09
J&J USD 78.47B 0 2025-09
Karyopharm Therapeutics USD -269.26M 30.33M 2025-09
Merck USD 51.85B 2.79B 2025-09
Novartis USD 44.75B 2.7B 2025-09
Omeros USD -228.68M 15.13M 2025-06
Pfizer USD 92.8B 4.11B 2025-09
Roche Holding CHF 33.8B 758M 2025-12
Sangamo BioSciences USD 19.6M 14.7M 2025-06
Sanofi EUR 71.71B 1.55B 2025-12
Sarepta Therapeutics USD 1.32B 37.26M 2025-09
Tectonic Therapeutic USD 267.53M 16.24M 2025-09
Ultragenyx Pharmaceutical USD 9.16M 142.13M 2025-09
Vertex Pharmaceuticals USD 17.32B 143.4M 2025-09


Sangamo BioSciences Capitale Sociale E Riserve - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.